Back to results
US 5,686,269 AGranted
Method of diagnosing Alzheimer's disease by detecting the level of cathepsin D in cerebrospinal fluid
AssigneeThe McLean Hospital Corporation
InventorRalph A. Nixon
Life of this patent
Estimating the term…
Abstract
Disclosed is a method of diagnosing Alzheimer's disease in a patient by measuring the level of cathepsin D in the patient's cerebrospinal fluid.
Claims8
A method for diagnosing probable Alzheimer's disease in a patient, said method comprising determining the level of cathepsin D in cerebrospinal fluid of said patient, and comparing said level of cathepsin D to normal levels, wherein an increase in said cathepsin D level relative to normal indicates a diagnosis of probable Alzheimer's disease in said patient.
Dependencies are inferred from the claim text.